Pregnancy and heart disease

Maternal heart disease has emerged as a major threat to safe motherhood and women`s long-term cardiovascular health. In the United States, disease and dysfunction of the heart and vascular system as “cardiovascular disease” is now the leading cause of death in pregnant women and women in the postpartum period accounting for 4.23 deaths per 100,000 live births, a rate almost twice that of the United Kingdom. The most recent data indicate that cardiovascular diseases constitute 26.5% of U.S. pregnancy-related deaths. Of further concern are the disparities in cardiovascular disease outcomes, with higher rates of morbidity and mortality among nonwhite and lower-income women. Contributing factors include barriers to pre-pregnancy cardiovascular disease assessment, missed opportunities to identify cardiovascular disease risk factors during prenatal care, gaps in high-risk intrapartum care, and delays in recognition of cardiovascular disease symptoms during the puerperium. The purpose of this document is to explain the prevalence and effects of heart disease in pregnant and postpartum women.  Provide guidelines for prenatal and postpartum early identification and risk factor correction. Outline common cardiovascular diseases that cause morbidity and mortality during pregnancy and after childbirth. Explain existing or newly acquired recommendations for the care of pregnant and postnatal women with heart disease. Present a comprehensive intergestational care plan for women with heart disease. Cardiovascular disease affects about 1-4% of the pregnancies of nearly 4 million people in the United States each year. The frequency of pregnancy in women with congenital and acquired heart disease is increasing. In developed countries, the morbidity and mortality rates of pregnant women with congenital heart disease are relatively stable at 11% and 0.5%, respectively. However, in the United States, maternal congenital heart disease increased linearly significantly from 2000 to 2010 (6.4 to 9.0 per 10,000 hospitalizations for childbirth), and maternal mortality from acquired heart disease was high. It's still expensive. From 2002 to 2011, 22.2% of maternal deaths in Illinois were due to cardiovascular disease, of which 97.1% were due to acquired heart disease. This increasing trend in maternal mortality associated with cardiovascular disease may be due to acquired heart disease.

Comments

Post a Comment

Popular posts from this blog

Variant PNLDC1, Defective piRNA Processing, and Azoospermia

Image
  P-element– precipitated wimpy testis (PIWI)–interacting RNAs (piRNAs) are short (21to 35 nucleotides in length) and noncoding and are observed nearly solely in germ cells, in which they adjust aberrant expression of transposable factors and post meiotic gene expression. Critical to the processing of piRNAs is the protein poly(A)- precise RNase-like area containing 1 (PNLDC1), which trims their 3′ ends and, whilst disrupted in mice, reasons azoospermia and male infertility. We carried out exome sequencing on DNA samples from 924 guys who had obtained an analysis of nonobstructive azoospermia. Testicular-biopsysamples have been analyzed through histologic, immunohistochemical hybridization, reverse-transcriptase–quantitative-polymerase-chain- response assay, and small-RNA sequencing Four unrelated guys of Middle Eastern descent who had nonobstructive azoospermia have been discovered to hold mutations in PNLDC1: the primary affected person had a biallelic stop–advant
Read more

Association Between Menstrual Cycle Length and Coronavirus Disease 2019 (COVID-19) Vaccination.

Image
To assess whether vaccination against coronavirus disease 2019 is associated with changes in cycle or menstrual length in vaccinated individuals compared to unvaccinated cohorts. We used the Natural Cycles application to analyze the positively recorded menstrual cycle data. US citizens aged 18-45 years, 3 consecutive cycles before the first vaccination (cycles 4-6), or a normal cycle length of 6 cycles (24-38 days) if not vaccinated there is. Period Included period. Averages within individual variations in cycle and menstrual length were calculated (3 cycles before vaccination vs. the first and second dosing cycles of the vaccinated cohort, and the first 3 cycles vs. the non-vaccinated cohort. Cycles 4 and 5). A mixed-effects model was used to estimate adjusted differences in cycle and menstrual length changes between vaccinated and non-vaccinated cohorts. We included 3,959 subjects (2,403 vaccinated; 1,556 unvaccinated). The majority of the vaccinated cohorts received the PfizerBioN
Read more

Women's Experience of Their First Sexual Encounter After Pelvic Reconstructive Surgery

Image
  This qualitative study recruited women who planned to undergo POP or UI surgery and who identified themselves as sexually active. Routine consultations on restorative activities will be provided 4 to 6 weeks after the operation. Participants completed the interview 2 to 4 months after the operation. The interview is recorded, identified and transcribed.Two independent researchers coded transcripts for the main topics; differences were arbitrated by the investigation team. Use Dedoose software for analysis. Twenty patients with an average age of 52.4 years participated in the study. The majority claimed to be white (85%), a quarter had a history of hysterectomy, and 15% had undergone previous pelvic reconstruction surgery. Nineteen (95%) patients resumed sexual intercourse 2-4 months after surgery. Major themes such as external influences, conflicting emotions, uncertainty, sexual change and stability, normalization, a nd self-image have reached
Read more